ciprofloxacin has been researched along with cefaclor anhydrous in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (9.30) | 18.7374 |
1990's | 15 (34.88) | 18.2507 |
2000's | 6 (13.95) | 29.6817 |
2010's | 17 (39.53) | 24.3611 |
2020's | 1 (2.33) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Guo, H | 1 |
Johnson, DM; Jones, RN | 1 |
Beale, AS; Gisby, J; Wightman, BJ | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Sato, K; Suzuki, Y; Tanaka, S; Yokota, N | 1 |
Houben, AW; Philips, JH; Stobberingh, EE | 1 |
Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
Niki, Y; Soejima, R; Tasaka, Y; Umeki, S; Watanabe, M | 1 |
Barry, AL | 1 |
Iwaku, M; Yoshiba, K; Yoshiba, N | 1 |
Asikainen, S; Forsblom, B; Jousimies-Somer, H; Pajukanta, R; Piekkola, M | 1 |
Hoshino, E; Noda, T; Sato, T; Uematsu, H | 1 |
Alaluusua, S; Asikainen, S; Jousimies-Somer, H; Pajukanta, R; Saarela, M | 1 |
Andrews, JM; Brenwald, N; Wise, R | 1 |
Hori, R; Hoshino, E; Kohno, S | 1 |
Belousov, IuB; Efremenkova, OV; Komarova, VP; Sokolov, AV; Tishchenkova, IF | 1 |
Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
Preston, DA; Turik, M | 1 |
Belousov, IuB; Efremenkova, OV; Komarova, VP | 1 |
Akman, M; Arseven, O; Aydin Tosun, G; Erelel, M; Erk, M; Göylüsün, V; Gür, A; Ilvan, A; Koşar, F; Müsellim, B; Oztürk, S; Soysal, F; Türker, H; Tutluoglu, B; Umut, S; Unutmaz, S; Vahapoglu, H; Yildirim, N; Yilmaz Kuyucu, T; Yilmaz, N | 1 |
Chiba, A; Harada, S; Hasegawa, M; Kaneko, A; Kobayashi, I; Koyama, H; Matsuzaki, K; Omika, K; Sasaki, J; Sato, Y | 1 |
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M | 1 |
Imparato, JC; Oda, M; Pinheiro, SL; Simionato, MR | 1 |
Gomber, C; Saxena, S | 1 |
Diogenes, A; Ferraz, CC; Ruparel, NB; Teixeira, FB | 1 |
Ferreira, JM; Menezes, VA; Pinheiro, SL; Sampaio, FC | 1 |
Bezgin, T; Celik, BN; Sönmez, H; Yilmaz, AD | 1 |
Akcay, M; Arslan, H; Kavrık, F; Yasa, B; Yasa, E | 1 |
Akçay, M; Arslan, H; Çakici, F; Saygili, G; Topçuoğlu, G; Topçuoğlu, HS | 1 |
Akcay, M; Arslan, H; Çakir, M; Dalli, M; Gok, A; Yasa, B | 1 |
Alagl, A; AlHumaid, J; Bedi, S; Hassan, K | 1 |
Abdelbacki, AMM; El-Gebaly, RH; Fadel, MA; Mohamed, SA | 1 |
Çakici, F; Fundaoğlu Küçükekenci, F; Küçükekenci, AS | 1 |
Caldeira, CL; Oliveira, AP; Sipert, CR | 1 |
Caldeira, CL; Holzhausen, M; Rahhal, JG; Rovai, EDS; Santos, CFD; Sipert, CR | 1 |
Alahmari, S; Alfaraj, F; Alfawaz, H; Alqedairi, A; Alsaad, N; Alsubait, S | 1 |
3 review(s) available for ciprofloxacin and cefaclor anhydrous
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Isatin derivatives and their anti-bacterial activities.
Topics: Anti-Bacterial Agents; Bacteria; Humans; Isatin; Structure-Activity Relationship | 2019 |
5 trial(s) available for ciprofloxacin and cefaclor anhydrous
Article | Year |
---|---|
[Selection of antibacterial therapy for treatment of infections in elderly patients].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Quinolones; Respiratory Tract Infections | 1998 |
Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society COPD Working Group.
Topics: Ampicillin; Anti-Infective Agents; Azithromycin; Cefaclor; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Sulbactam; Treatment Outcome | 1999 |
Antibacterial activity of glass-ionomer cement containing antibiotics on caries lesion microorganisms.
Topics: Anti-Bacterial Agents; Bacteria; Cefaclor; Child; Child, Preschool; Ciprofloxacin; Colony Count, Microbial; Dental Caries; Dental Restoration, Permanent; Dentin; Glass Ionomer Cements; Humans; Metronidazole; Microscopy, Electron, Scanning; Statistics, Nonparametric | 2005 |
Use of glass ionomer cement containing antibiotics to seal off infected dentin: a randomized clinical trial.
Topics: Anti-Bacterial Agents; Cariostatic Agents; Cefaclor; Chi-Square Distribution; Child; Child, Preschool; Ciprofloxacin; Dental Atraumatic Restorative Treatment; Dental Caries; Dental Cavity Lining; Dentin; Double-Blind Method; Female; Glass Ionomer Cements; Humans; Male; Metronidazole; Tooth, Deciduous | 2013 |
The effect of intracanal medicaments used in Endodontics on the dislocation resistance of two calcium silicate-based filling materials.
Topics: Anti-Bacterial Agents; Calcium; Calcium Compounds; Calcium Hydroxide; Cefaclor; Ciprofloxacin; Dental Bonding; Endodontics; Humans; Metronidazole; Root Canal Filling Materials; Root Canal Irrigants; Silicates | 2020 |
35 other study(ies) available for ciprofloxacin and cefaclor anhydrous
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Topics: beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1992 |
Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefaclor; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Female; Humans; Mice; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 1991 |
[Antibacterial activity of ciprofloxacin against fresh clinical isolates from superficial suppurative foci].
Topics: Amoxicillin; Bacteria; Cefaclor; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Suppuration | 1991 |
In vitro activity of cefpodoxime, a new oral cephalosporin.
Topics: beta-Lactamases; Cefaclor; Cefpodoxime; Ceftizoxime; Ciprofloxacin; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas | 1989 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
Therapeutic effect of fleroxacin against experimental pneumonia in mice.
Topics: Animals; Anti-Infective Agents; Cefaclor; Ciprofloxacin; Fleroxacin; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Pipemidic Acid | 1988 |
In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Chemical Phenomena; Chemistry; Ciprofloxacin; Erythromycin; Gram-Positive Bacteria; Oxazoles; Oxazolidinones; Vancomycin | 1988 |
Effects of antibacterial capping agents on dental pulps of monkeys mechanically exposed to oral microflora.
Topics: Animals; Calcium Hydroxide; Calcium Phosphates; Cefaclor; Ciprofloxacin; Dental Pulp Capping; Dental Pulp Exposure; Dental Pulp Necrosis; Dentin, Secondary; Drug Therapy, Combination; Macaca; Metronidazole; Minocycline; Wound Healing | 1995 |
Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Doxycycline; Erythromycin; Evaluation Studies as Topic; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Porphyromonas gingivalis; Tetracyclines | 1994 |
In vitro antimicrobial susceptibility to combinations of drugs on bacteria from carious and endodontic lesions of human deciduous teeth.
Topics: Amoxicillin; Bacteria, Anaerobic; Cefaclor; Child; Child, Preschool; Ciprofloxacin; Dental Caries; Dental Pulp Diseases; Drug Therapy, Combination; Fosfomycin; Humans; Metronidazole; Microbial Sensitivity Tests; Miocamycin; Tooth, Deciduous | 1993 |
In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans.
Topics: Aggregatibacter actinomycetemcomitans; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Metronidazole; Penicillin G; Penicillin Resistance; Serotyping; Tetracycline; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone.
Topics: Amoxicillin; Anti-Infective Agents; Bacteroides fragilis; Cefaclor; Chlamydia trachomatis; Chlamydophila pneumoniae; Ciprofloxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Norfloxacin; Piperazines; Protein Binding; Quinolones; Staphylococcus | 1993 |
Bactericidal eradication from carious lesions of prepared abutments by an antibacterial temporary cement.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Cefaclor; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Crowns; Dental Abutments; Dental Caries; Dental Leakage; Dental Restoration, Temporary; Humans; Metronidazole; Middle Aged; Polycarboxylate Cement; Tooth Preparation, Prosthodontic | 1997 |
[Treatment of lower respiratory tract infections in the elderly].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Bronchitis; Cefaclor; Cephalosporins; Chronic Disease; Ciprofloxacin; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillins | 1997 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
Cefaclor: a contemporary look at susceptibility of key pathogens from around the globe.
Topics: Anti-Infective Agents; Cefaclor; Cephalosporins; Ciprofloxacin; Escherichia coli; Haemophilus influenzae; Methicillin Resistance; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Staphylococcus aureus | 1998 |
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefaclor; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Levofloxacin; Methicillin; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillins | 1999 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
[Susceptibility of Branhamella catarrhalis to antibiotics].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefotaxime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Erythromycin; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 2004 |
Comparative in vitro antimicrobial procedural efficacy for susceptibility of Staphylococcus aureus, Escherichia coil and Pseudomonas species to chloramphenicol, ciprofloxacin and cefaclor.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefaclor; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus aureus | 2008 |
Direct effect of intracanal medicaments on survival of stem cells of the apical papilla.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Calcium Hydroxide; Cefaclor; Cell Survival; Cells, Cultured; Ciprofloxacin; Dental Papilla; Dose-Response Relationship, Drug; Female; Humans; Metronidazole; Molar, Third; Root Canal Irrigants; Statistics, Nonparametric; Stem Cells | 2012 |
Concentrated platelet-rich plasma used in root canal revascularization: 2 case reports.
Topics: Anti-Bacterial Agents; Cefaclor; Child; Ciprofloxacin; Dental Pulp Cavity; Disinfection; Humans; Male; Metronidazole; Neovascularization, Physiologic; Platelet-Rich Plasma | 2014 |
Spectrophotometric analysis of crown discoloration induced by various antibiotic pastes used in revascularization.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Calcium Hydroxide; Cattle; Cefaclor; Ciprofloxacin; Color Perception; Doxycycline; Metronidazole; Random Allocation; Regeneration; Root Canal Filling Materials; Root Canal Irrigants; Root Canal Preparation; Root Canal Therapy; Sodium Hypochlorite; Spectrophotometry; Time Factors; Tooth Crown; Tooth Discoloration | 2014 |
The effect of medicaments used in endodontic regeneration technique on the dislocation resistance of mineral trioxide aggregate to root canal dentin.
Topics: Adhesiveness; Aluminum Compounds; Anti-Bacterial Agents; Calcium Compounds; Calcium Hydroxide; Cefaclor; Ciprofloxacin; Dental Bonding; Dental Pulp Cavity; Dentin; Drug Combinations; Humans; Materials Testing; Metronidazole; Minocycline; Oxides; Random Allocation; Root Canal Irrigants; Root Canal Preparation; Silicates; Sodium Hypochlorite; Stress, Mechanical; Surface Properties | 2014 |
Comparison of bond strength of self-etch adhesive to pulp chamber dentin after placement of calcium hydroxide and various antibiotic pastes.
Topics: Amoxicillin; Anti-Bacterial Agents; Calcium Hydroxide; Cefaclor; Ciprofloxacin; Composite Resins; Dental Bonding; Dental Pulp Cavity; Dental Stress Analysis; Dentin; Dentin-Bonding Agents; Drug Combinations; Edetic Acid; Humans; Materials Testing; Metronidazole; Minocycline; Random Allocation; Resin Cements; Root Canal Irrigants; Sodium Hypochlorite; Stress, Mechanical; Tensile Strength | 2015 |
Use of platelet-rich plasma for regeneration in non-vital immature permanent teeth: Clinical and cone-beam computed tomography evaluation.
Topics: Aluminum Compounds; Anti-Bacterial Agents; Bone Density; Calcium Compounds; Cefaclor; Child; Ciprofloxacin; Cone-Beam Computed Tomography; Dental Cements; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Metronidazole; Neovascularization, Physiologic; Oxides; Periapical Periodontitis; Platelet-Rich Plasma; Regeneration; Silicates; Thrombosis; Tissue Scaffolds; Tooth Root | 2017 |
Biophysical control of the growth of Agrobacterium tumefaciens using extremely low frequency electromagnetic waves at resonance frequency.
Topics: Agrobacterium tumefaciens; Amikacin; Anti-Bacterial Agents; Carbenicillin; Cefaclor; Chloramphenicol; Ciprofloxacin; DNA, Bacterial; Electromagnetic Radiation; Fluoroquinolones; Gatifloxacin; Gentamicins; Plant Tumors; Rifampin; Solanum lycopersicum | 2017 |
Spectrophotometric analysis of discoloration and internal bleaching after use of different antibiotic pastes.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Ciprofloxacin; Doxycycline; Humans; Hydrogen Peroxide; In Vitro Techniques; Lasers, Solid-State; Metronidazole; Minocycline; Spectrophotometry; Tooth Bleaching; Tooth Discoloration | 2019 |
Cytotoxicity of intracanal dressings on apical papilla cells differ upon activation with E. faecalis LTA.
Topics: Adolescent; Analysis of Variance; Anti-Bacterial Agents; Calcium Hydroxide; Cefaclor; Cell Survival; Cells, Cultured; Ciprofloxacin; Dental Papilla; Enterococcus faecalis; Female; Humans; Lipopolysaccharides; Male; Metronidazole; Reproducibility of Results; Root Canal Irrigants; Teichoic Acids; Time Factors; Tooth Apex | 2019 |
Root canal dressings for revascularization influence in vitro mineralization of apical papilla cells.
Topics: Analysis of Variance; Anti-Bacterial Agents; Calcium Hydroxide; Cefaclor; Cell Differentiation; Cell Proliferation; Cell Survival; Cells, Cultured; Ciprofloxacin; Dental Papilla; Formazans; Humans; Metronidazole; Reproducibility of Results; Root Canal Irrigants; Tetrazolium Salts; Time Factors | 2019 |